OCP/DARS IDIQ 5 year purchase of cells
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the purchase of cells specifically intended for studying microphysiological systems. The contract is classified under NAICS code 541714 for Research and Development in Biotechnology and is anticipated to have a solicitation release date of July 1, 2026, with an estimated award date of September 1, 2026. This procurement is not set aside for any specific type of business and represents a new requirement for the agency.
While specific award values and precise quantities are not detailed in the forecast, the contract involves purchasing cells for advanced biotechnological research purposes. Christopher Scott is identified as a key federal contact, with a contact email of christopher.scott@fda.hhs.gov, and the organization will be conducting its procurement through the Food and Drug Administration. The point of contact email for potential inquiries is currently listed as tbd@fda.gov, suggesting that additional details may be forthcoming as the solicitation date approaches.
Forecast text
Purchase of cells for studying microphysiological systems.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast